Anthropic has appointed Novartis (NVS) CEO Vas Narasimhan to its board, its second board addition in recent months, as it eyes an IPO and pushes further into health care, The Wall Street Journal’s Kate Clark reports. The company added former Microsoft (MSFT) and GM (GM) executive Chris Liddell to its board in February.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- 3 Best Vanguard Dividend ETFs for Reliable Passive Income in 2026
- Trump Trade: U.S. strengthens tariffs on steel, aluminum, copper imports
- AZN, NVO, NVS: What Does Trump’s New 100% Tariff Mean for Pharma Giants?
- White House says imposing tariffs on patented pharmaceutical products
- Trump Trade: President says Iran war will still take weeks